Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
MNOV
Stock Latest News
Ratings
Jason McCarthy Reiterates Buy on MediciNova, Maintains $6 Price Target Ahead of Key ALS and Metabolic Disease Readouts
21h ago
MNOV
Premium
Ratings
Analyst Reiterates Buy on MediciNova with Unchanged $10 Price Target Amid Progress of Lead Clinical Programs
2d ago
MNOV
Premium
Ratings
MediciNova: Differentiated NAFLD/MASH Profile and Complementary APOC3 Positioning Support Unchanged $6 Target and Buy Rating
24d ago
MNOV
Premium
The Fly
Roth Capital biopharmaceuticals analyst holds a webinar
1M ago
BIIB
COYA
Premium
Ratings
Analyst Reiterates Buy on MediciNova as Advancing Pipeline and Upcoming ALS Catalysts Support Unchanged $6 Price Target
2M ago
MNOV
Premium
Company Announcements
MediciNova Shareholders Reject Proposal to Increase Authorized Stock
2M ago
8K
MNOV
Premium
Ratings
Analyst Initiates Buy on MediciNova, Citing Pivotal Tipelukast and Ibudilast Catalysts to Support $10 Price Target
3M ago
MNOV
Premium
Ratings
Medicinova: Buy Rating Reiterated as Pipeline Advances and Cash Runway Extends, $6 Price Target Maintained
3M ago
MNOV
Premium
The Fly
MediciNova’s peer-reviewed ibudilast study advances clinical translation
4M ago
MNOV
Premium
The Fly
Super Micro downgraded, MongoDB upgraded: Wall Street’s top analyst calls
5M ago
BIP
BOX
Premium
The Fly
Maxim resumes MediciNova at Buy on potential value-driving data events this year
5M ago
MNOV
Premium
The Fly
MediciNova resumed with a Buy at Maxim
5M ago
MNOV
Premium
The Fly
MediciNova initiated with a Buy at H.C. Wainwright
5M ago
MNOV
Premium
The Fly
MediciNova management to meet with Maxim
6M ago
MNOV
Premium
The Fly
MediciNova issues letter to shareholders
7M ago
MNOV
Premium
The Fly
MediciNova initiated with a Buy at Lucid Capital
7M ago
MNOV
Premium
Company Announcements
MediciNova Establishes Flexible At-The-Market Equity Program
8M ago
8K
MNOV
Premium
The Fly
MediciNova completes patient enrollment in neuropathy trial of MN-166
8M ago
MNOV
Premium
The Fly
MediciNova files $300M mixed securities shelf
8M ago
MNOV
Premium
The Fly
MediciNova names Dr. Christopher Breder as Clinical and Regulatory Advisor
9M ago
MNOV
Premium
The Fly
MediciNova completes patient enrollment in MN-001-NATG-202 trial
9M ago
MNOV
Premium
The Fly
MediciNova compounds demonstrate novel therapeutic approach for Atherosclerosis
10M ago
MNOV
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
